Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration Two-Year Results

Overview of attention for article published in Ophthalmology, May 2012

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 6 news outlets
blogs: 1 blog
policy: 5 policy sources
twitter: 12 X users
patent: 35 patents

facebook: 1 Facebook page
wikipedia: 3 Wikipedia pages
reddit: 1 Redditor
f1000: 1 research highlight platform
guideline: 6 clinical guideline sources

Readers on

mendeley: 642 Mendeley

So far, Altmetric has seen 1 Reddit thread.

there's plenty of discussion in that aspect, it seems to be...

User equeco, in the /r/medicine: a subreddit for medical professionals subreddit, 01 Dec 2013

there's plenty of discussion in that aspect, it seems to be that the risk of adverse events is slightly higer with bevacizumab.

This page shows the most recent Reddit threads that mention this research output. Click here to find out how to access more activity.